Platelet Activation Is Not Always Associated With Platelet-Related Plasma microRNA Abundance - Results From a

Stefan Heber1, Markus Laky2, Isabella Anscheringer3

  • 1Center for Physiology and Pharmacology, Institute of Physiology, Medical University of Vienna, Vienna, Austria.

Insights

Investigating microRNAs (miRNAs) as platelet biomarkers in periodontal disease revealed no correlation between miRNA levels and platelet function. These specific circulating miRNAs are unlikely to be useful for assessing platelet activity in this patient group.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Platelet function is crucial in various diseases, but accurate assessment is challenging due to platelet activation.
  • Stable surrogate markers for platelet function are needed, with circulating microRNAs (miRNAs) being a potential candidate.
  • Periodontal disease impacts systemic health, including potential effects on platelet activity.

Purpose of the Study:

  • To evaluate the suitability of specific plasma microRNAs (miRNAs) as biomarkers for platelet function and activation.
  • To determine if periodontal treatment influences circulating miRNA levels and their correlation with platelet function.
  • To investigate the origin of circulating miRNAs in the context of platelet activity.

Main Methods:

  • Plasma samples from a randomized controlled trial on periodontal treatment were analyzed.
  • Platelet function was assessed using flow cytometry.
  • Abundance of 15 specific miRNAs was quantified using quantitative polymerase chain reaction (qPCR).

Main Results:

  • Periodontal treatment did not significantly alter the levels of the investigated miRNAs.
  • No correlation was found between baseline or post-treatment miRNA levels and platelet activation or reactivity indices.
  • Evidence supporting the release of these miRNAs by platelets was not observed.

Conclusions:

  • The investigated circulating miRNAs are unlikely to serve as reliable biomarkers for platelet function in patients with periodontal disease.
  • This study cautions against the universal application of previously identified platelet activation-dependent circulating miRNAs across all patient cohorts.
  • Further research is needed to identify robust biomarkers for platelet function in specific disease contexts.